Who we are

WHO WE ARE

Biomedcode is a Contract Research Organization (CRO) specialized in Preclinical Testing.

We are experts in the development of mouse models of human pathologies as specialized tools for the efficient evaluation of human therapeutics and we offer a unique collection of disease models humanized for specific therapeutic targets. 

A BIT OF HISTORY

Biomedcode was founded in 2006 as a spin-off company of the Biomedical Sciences Research Center “Alexander Fleming”. Our Arthritis models (Tg197 and Tg5453) were instrumental in providing the in vivo proof of concept on the pathogenic role of TNF in the development of chronic polyarthritis and the therapeutic value of anti-huTNF antibodies.

MEDIUM_CUTE MOUSE_shutterstock_427832815

PRIME YOUR DRUGS FOR SUCCESS TODAY

WHAT WE OFFER

We offer specialized preclinical testing using unique humanized transgenic mouse models mimicking human diseases

Human Diseases:

Acute inflammation / Rheumatoid Arthitis Spondyloarthropathy Intestinal Inflamation / Psoriasis Multiple Sclerosis / Osteoporosis

Our Services:

Preclinical screening and efficacy evaluation / Sample collection for PK/PD analysis / Cellular and molecular assays / Method development

12

YEARS OF EXPERIENCE

75

CLIENTS

110

THERAPEUTICS TESTED

WHY US

We offer Preclinical Services Customized to your Needs. Our extended portfolio of unique mouse disease models, together with our long-lasting expertise in preclinical testing, our standardized procedures as well as the customer oriented scientific consultation and services we provide, constitute our unmatched competitive advantage.

Our resources include a team of highly educated and experienced scientists and technicians that operate in our SPF research animal facility and state-of-the-art laboratory. Our lead in the field of Preclinical Testing is also supported by our highly active Research & Development program that aims at the development and characterization of novel humanized animal disease models. Our preclinical services combine high-end research with cutting edge technologies.